Fresh Equities
Raises
Research
About
Looking for more information?

Contact our responsive and friendly client services team any time.

RHINOMED LIMITED

INVESTOR PRESENTATION - RHINOMED LIMITED

ASX:RNO

RHINOMED LIMITED

Health Care

Rhinomed Limited (RNO, formerly Consegna Group Limited) is a nasal and respiratory medical technology company based in Melbourne,Australia; including (i) sport & exercise, (ii) wellbeing (appetite & anxiety), (iii) sleep/snoring & sleep apnea, and (iv) drug delivery (migraine & allergies) market.

Read more

Market Cap

39.34m

Price at Close

$0.155

4w avg. Volume

1.26m

4w avg. Turnover

$169.30k

Announcements
announcementt+2 movementdate
  • Change in substantial holding JMcB

    Shareholder Details

  • -

    24 Sep 2020

-

24 Sep 2020
  • Change of Director's Interest Notice - RD

    Shareholder Details

  • -

    23 Sep 2020

-

23 Sep 2020
  • Rhinomed Limited Audited Financial Report FY20

    Periodic Reports

  • +7.14%

    20 Sep 2020

+7.14%

20 Sep 2020
  • Rhinomed developing new nasal swab

    Progress Report

  • +57.89%

    14 Sep 2020

+57.89%

14 Sep 2020
  • Preliminary Final Report

    Periodic Reports · Market sensitive

  • +2.60%

    26 Aug 2020

+2.60%

26 Aug 2020
  • Statement Pursuant to Listing Rule 4.7C

    Commitments test entity quarterly reports · Market sensitive

  • -4.76%

    16 Aug 2020

-4.76%

16 Aug 2020
  • Appendix 4C - quarterly

    Commitments test entity quarterly reports · Market sensitive

  • -5.26%

    22 Jul 2020

-5.26%

22 Jul 2020
  • Change in substantial holding (WG)

    Shareholder Details

  • +8.22%

    14 Jul 2020

+8.22%

14 Jul 2020
  • Notification of change in Auditor

    Company Administration

  • -2.67%

    10 Jul 2020

-2.67%

10 Jul 2020
  • Ceasing to be a substantial holder - PS

    Shareholder Details

  • +2.74%

    02 Jul 2020

+2.74%

02 Jul 2020
Market Data

Current Price

$0.155

52WK HIGH

$0.3

52WK LOW

$0.06

1YR RETURN

-48.33%

1YR RETURN VS. SECTOR

-75.61%

90 DAY RETURN

+106.67%

ASX RANK

1,132

/2,018

SECTOR RANK

19

/31

SHARES OUTSTANDING

253.81m
ASX:RNO

RHINOMED LIMITED

Health Care

Rhinomed Limited (RNO, formerly Consegna Group Limited) is a nasal and respiratory medical technology company based in Melbourne,Australia; including (i) sport & exercise, (ii) wellbeing (appetite & anxiety), (iii) sleep/snoring & sleep apnea, and (iv) drug delivery (migraine & allergies) market.

Read more

Market Cap

39.34m

Price at Close

$0.155

4w avg. Volume

1.26m

4w avg. Turnover

$169.30k

ASX:RNO is not raising right now

Want to invest?

Fresh Equities

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.

Contact Us

(03) 9028 2888

clients@freshequities.com

Address

Level 7, 388 Bourke St
Melbourne VIC 3000
Australia

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.